Bupropion
Wellbutrin, Zyban
Also known as: Lamisil
Potent CYP2D6 inhibitor. Oral form has long half-life.
Severity
Major risk
Mechanism
CYP2D6 inhibition
Protocol Status
Pre-arrival washout (under your prescribing physician)
Restart Delay
Physician discretion
What "Major risk" Means
Serious clinical risk requiring physician-led tapering, washout, and monitoring. Treatment may proceed once the medication is appropriately cleared or transitioned.
Clinical Action
Discontinue oral terbinafine minimum 14 days before treatment. Topical is fine.
Where the Washout Happens
Pre-arrival washout (under your prescribing physician)
Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose.
Pre-Treatment Washout Window
14 days minimum before treatment.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
Ibogaine is metabolised primarily by hepatic CYP2D6 into noribogaine. Drugs that inhibit CYP2D6 slow this conversion, so plasma ibogaine rises to higher peaks and stays there longer. Higher peaks deepen the experience and amplify QTc prolongation. CYP2D6-inhibiting medications are tapered and discontinued well before treatment to ensure predictable pharmacokinetics.
Same Mechanism
Same Severity Tier
Opioid receptor potentiation
Methadose, Dolophine
Opioid receptor potentiation
Suboxone, Subutex
Opioid receptor potentiation
Duragesic, Sublimaze
Opioid receptor potentiation
Oxycontin, Percocet
Opioid receptor potentiation
Vicodin, Norco
Opioid receptor potentiation
Ms Contin, Kadian
Common Questions
Major risk. Potent CYP2D6 inhibitor. Oral form has long half-life. Discontinue oral terbinafine minimum 14 days before treatment. Topical is fine.
Pre-arrival washout (under your prescribing physician). Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose. 14 days minimum before treatment.
CYP2D6 inhibition. Ibogaine is metabolised primarily by hepatic CYP2D6 into noribogaine. Drugs that inhibit CYP2D6 slow this conversion, so plasma ibogaine rises to higher peaks and stays there longer. Higher peaks deepen the experience and amplify QTc prolongation. CYP2D6-inhibiting medications are tapered and discontinued well before treatment to ensure predictable pharmacokinetics.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Terbinafine — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 103 medications in the A–Z directory.